22nd Century Group signs exclusive 3-year license and distribution deal with Cookies

22nd Century Group, Inc.

Exclusive license to manufacture and distribute Cookies branded hemp-derived products in US for 3 years, with option to extend.
22nd Century to issue 5 million shares of unregistered common stock to Cookies, subject to one-year lock-up.
Monthly license fee equal to a percentage of net profits generated under the agreement.
GVB Biopharma, a 22nd Century subsidiary, has manufactured Cookies products for the past three years.
Distribution targets up to 18 markets and approximately 60,000 retail stores in 2023.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

22nd Century Group, Inc. entered into License and Distribution Agreement with Cookies Creative Consulting & Promotions, Inc. (effective 2023-04-04).

Action: entry
Agreement: license
Counterparty: Cookies Creative Consulting & Promotions, Inc.
Effective: 2023-04-04

Exact text from the filing

On April 4, 2023, a subsidiary of 22nd Century Group, Inc. (the “Company”) entered into a License and Distribution Agreement (the “Agreement”) with Cookies Creative Consulting & Promotions, Inc. (“Cookies”).

View on SEC.gov

245 material agreements filed in the last 30 days. Browse all material agreements →

22nd Century Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-042189

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.